Identifying pain response predictors for endoscopic treatment in chronic pancreatitis
Predictive Biosignature for Endoscopic Therapy for Chronic Pancreatitis Pain
This study is looking to find out which patients with chronic pancreatitis are likely to benefit from special treatments to relieve their pain, using some cool techniques to understand both their physical and emotional experiences, so that doctors can provide more personalized care and help reduce the need for pain medications.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10794609 on NIH RePORTER |
What this research studies
This research investigates how to predict which patients with chronic pancreatitis will respond to endoscopic therapies for pain relief. It utilizes advanced techniques such as electroencephalography (EEG) and quantitative sensory testing (QST) to assess both physical and psychological factors affecting pain. By combining these methods, the study aims to create a predictive biosignature that can help tailor treatments to individual patients, potentially reducing reliance on opioids and improving pain management outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from chronic pancreatitis, particularly those experiencing pain related to ductal obstruction.
Not a fit: Patients without chronic pancreatitis or those whose pain is not related to ductal obstruction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective pain management strategies for patients with chronic pancreatitis, reducing the need for opioids.
How similar studies have performed: Other research has shown promise in using multimodal approaches for pain prediction, suggesting that this method could be effective.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Doan, Lisa — New York University School of Medicine
- Study coordinator: Doan, Lisa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.